Zhang M - Search Results

1

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies.

Hu Y, Li J, Ni F, Yang Z, Gui X, Bao Z, Zhao H, Wei G, Wang Y, Zhang M, Hong R, Wang L, Wu W, Mohty M, Nagler A, Chang AH, van den Brink MRM, Li MD, Huang H. Hu Y, et al. Among authors: zhang m. Nat Commun. 2022 Sep 9;13(1):5313. doi: 10.1038/s41467-022-32960-3. Nat Commun. 2022. PMID: 36085303 Free PMC article. Clinical Trial.

2

Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.

Ye Y, Zheng W, Wang J, Hu Y, Luo Y, Tan Y, Shi J, Zhang M, Huang H. Ye Y, et al. Among authors: zhang m. Hematol Oncol. 2017 Dec;35(4):821-827. doi: 10.1002/hon.2310. Epub 2016 Jun 1. Hematol Oncol. 2017. PMID: 27245857

3

Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.

Zhang M, Fu H, Lai X, Tan Y, Zheng W, Shi J, Zhao Y, Lin M, He J, Cai Z, Luo Y, Huang H. Zhang M, et al. PLoS One. 2016 Oct 3;11(10):e0163599. doi: 10.1371/journal.pone.0163599. eCollection 2016. PLoS One. 2016. PMID: 27695097 Free PMC article.

4

Hydroxychloroquine sensitizes chronic myeloid leukemia cells to Vγ9Vδ2 T cell-mediated lysis independent of autophagy.

Han B, Zhao Y, Lin Y, Fu S, Wang L, Zhang M, Tie R, Wang B, Luo Y, Liu L, Yu J, Huang H. Han B, et al. Among authors: zhang m. Int J Oncol. 2017 May;50(5):1810-1820. doi: 10.3892/ijo.2017.3934. Epub 2017 Mar 24. Int J Oncol. 2017. PMID: 28339029

5

mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation.

Lin Y, Wang B, Shan W, Tan Y, Feng J, Xu L, Wang L, Han B, Zhang M, Yu J, Yu X, Huang H. Lin Y, et al. Among authors: zhang m. Clin Immunol. 2018 Feb;187:122-131. doi: 10.1016/j.clim.2017.11.005. Epub 2017 Nov 10. Clin Immunol. 2018. PMID: 29132870

6

Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

Zhang A, Wu Y, Tan Y, Shi J, Zhao Y, Hu Y, Yu J, Zheng W, Lai X, Zhang M, Zhu Y, Ye Y, Huang Y, Fu S, Huang H, Luo Y. Zhang A, et al. Among authors: zhang m. Biol Blood Marrow Transplant. 2020 May;26(5):956-964. doi: 10.1016/j.bbmt.2020.01.006. Epub 2020 Jan 18. Biol Blood Marrow Transplant. 2020. PMID: 31962163 Free article.

7

Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies.

Zhu F, Wei G, Zhang M, Zhao H, Wu W, Yang L, Hu Y, Huang H. Zhu F, et al. Among authors: zhang m. Cell Transplant. 2020 Jan-Dec;29:963689720919434. doi: 10.1177/0963689720919434. Cell Transplant. 2020. PMID: 32314613 Free PMC article.

8

How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?

Zhang M, Huang H. Zhang M, et al. Front Immunol. 2020 Dec 15;11:611710. doi: 10.3389/fimmu.2020.611710. eCollection 2020. Front Immunol. 2020. PMID: 33384696 Free PMC article. Review.

9

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

Wu H, Shi J, Luo Y, Tan Y, Zhang M, Lai X, Yu J, Liu L, Fu H, Huang H, Zhao Y. Wu H, et al. Among authors: zhang m. JAMA Netw Open. 2021 Jan 4;4(1):e2034750. doi: 10.1001/jamanetworkopen.2020.34750. JAMA Netw Open. 2021. PMID: 33502484 Free PMC article.

10

CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia.

Hu Y, Zhou Y, Zhang M, Ge W, Li Y, Yang L, Wei G, Han L, Wang H, Yu S, Chen Y, Wang Y, He X, Zhang X, Gao M, Yang J, Li X, Ren J, Huang H. Hu Y, et al. Among authors: zhang m, zhang x. Clin Cancer Res. 2021 May 15;27(10):2764-2772. doi: 10.1158/1078-0432.CCR-20-3863. Epub 2021 Feb 24. Clin Cancer Res. 2021. PMID: 33627493 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57,195 results

Search Page